McDermott Will & Emery represented Iron Path Capital, while Spilman Thomas & Battle represented Chemours in the transaction. PureTech Scientific announced the acquisition of The Chemours Company’s...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Iron Path Capital in the transaction. Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, announced its...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Quad-C Management in the transaction. Quad-C Management, a leading middle market private equity firm, executed its investment in U.S. Endodontics Partners,...
You must be a Standard 1 Year member to access this content.
